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Primary axillary-subclavian vein thrombosis or
Paget-Schroetter syndrome is a serious problem, the
short- and long-term sequelae of which have only
recently been appreciated. The pathophysiology of
this syndrome remains poorly understood, and the
treatment is varied and controversial. Untreated,
symptomatic patients will sustain chronic disability
from venous obstruction, with arm swelling, pain,
and early exercise fatigue. This may lead to significant
loss of occupational productivity and quality of life,1
especially because most cases involve the patient’s
dominant arm.2,3 However, surgical intervention is
not without potential for serious complications,
including brachial palsy, chronic postoperative pain
syndromes, chylothorax, and phrenic nerve palsy.
The diagnosis of Paget-Schroetter syndrome is
suspected in the setting of an acute onset of symp-
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surgery and eight of nine patients (89%) treated without surgery sustained durable relief of
their symptoms and a return to their baseline level of physical activity. All patients who
underwent surgery maintained their venous patency on follow-up duplex scanning imaging.
Conclusion: Not all patients with primary axillary-subclavian vein thrombosis require
surgical intervention. A period of observation while patients are receiving oral antico-
agulation for at least 1 month allows the selection of patients who will do well with non-
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tomatic upper-extremity swelling, usually with an
antecedent episode of repetitive or sustained ipsilat-
eral abduction and external rotation in an otherwise
healthy individual.4 It is distinguished from sec-
ondary causes of axillary-subclavian thrombosis that
occur in the presence of predisposing mechanical or
physiologic factors, such as direct trauma, indwelling
catheter, or hypercoagulable state.
Successful treatment requires prompt diagnosis
and thrombolysis. Once the diagnosis is suspected, a
duplex ultrasound scan of the effected extremity is
obtained for noninvasive evaluation of deep venous
thrombosis. This is followed by a dedicated contrast
venogram. Specific catheter-directed thrombolysis
and intravenous heparin are started, and after
thrombolysis, the patients are converted to oral anti-
coagulation with warfarin.3,5
Controversy exists regarding the indications for
and the timing of surgical thoracic outlet decompres-
sion and other adjunctive vascular and endovascular
procedures in the treatment of this syndrome. This
study was designed to evaluate the efficacy of a treat-
ment algorithm for the management of primary sub-
clavian vein thrombosis, in which the decision
regarding the necessity for surgical intervention was
deferred for approximately 1 month to determine the
patient’s response to conservative therapy (Fig 2).
The decision to study this algorithm was based on
three factors: the findings in an earlier study from our
institution documented that not all patients with pri-
mary subclavian vein thrombosis required surgical
intervention for relief of their symptoms6; our service
had been seeing more patients referred because of
serious complications after thoracic outlet decom-
pression; and our experience that a delay in surgical
intervention allows resolution of the inflammation
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Fig 1. Right upper-extremity contrast venogram. A, Initial venogram demonstrating a completely
thrombosed right axillary-subclavian vein. B, Complete recanalization with abundant venous collater-
alization. C, Positional venography with the arm abducted and externally rotated showing the occlu-
sion of the veins with the maneuver.
A
B C
associated with vein thrombosis and thus makes the
dissection around the subclavian vein easier and safer.
PATIENTS AND METHODS
From June 1996 to June 1999, patients in whom
primary axillary-subclavian vein thrombosis was
diagnosed were enrolled in an algorithm of selective
surgical therapy (Fig 2). Follow-up examinations of
these patients were completed through November
1999. The clinical diagnosis of venous thrombosis
was made by means of the initial history and a phys-
ical examination demonstrating ipsilateral arm
swelling and pain, usually with an antecedent
episode of physical exertion involving the affected
extremity, and the absence of other mechanical or
physiologic risk factors, including intravenous
catheters and radiation phlebitis. When initially seen
at the authors’ institution, the patients immediately
underwent color-flow venous duplex ultrasound
scanning before any anticoagulation. When a deep
venous thrombosis was demonstrated by means of
the study, the patient was admitted for an urgent
contrast venogram with full visualization of the
venous system, from the level of the proximal fore-
arm to the innominate-superior vena caval conflu-
ence. Special attention was given to the region of the
shoulder girdle, and the images were obtained with
the arm in a neutral position and in the abduction
and external rotation.
Catheter-directed thrombolysis was started, with
the periodic advancement of the multi-sidehole infu-
sion catheters, as needed. Urokinase (Abbokinase,
Abbott Laboratories, Abbott Park, Ill) was used as a
means of initially lacing the clot and then was infused
at a dose of 120,000 to 180,000 IU/h. Infusions last-
ed from 24 to 72 hours, depending on the success of
the degree of thrombolysis that was demonstrated by
means of the venogram. Concurrent heparin infusion
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Fig 2. Diagram of the treatment algorithm.
was administered through the sidearm of the infusion
sheath at rates from 500 to 1200 U/h to obtain an
activated partial thromboplastin time of 60 to 80 sec-
onds. The success of thrombolysis was assessed by
means of serial venograms at 6- to 12-hour intervals.
Thrombolysis was stopped when any one or more of
these conditions were met: no interval change in the
angiographic appearance of the vein in two sequential
venograms, bleeding complications, biochemical evi-
dence of disseminated intravascular coagulopathy, or
72 hours of continuous infusion reached. In one
patient, recombinant tissue-type plasminogen activa-
tor (rt-PA, Activase, Genentech, San Francisco, Calif)
was used for thrombolysis because of the unavailabil-
ity of urokinase. The dose was 2 mg/h continuous
infusion. The remaining aspects of this thrombolysis
treatment protocol were unchanged from those of the
protocol with urokinase (Fig 1).
At the conclusion of thrombolysis, the patency of
the vein was assessed with a completion venogram
and read as either occluded, partially obstructed (>
50%), or patent. Positional venography was per-
formed with the abduction and external rotation of
the ipsilateral arm. Any positional impingement of
the main subclavian-axillary vein or collaterals was
noted. The patient was transitioned from intra-
venous heparin to warfarin and was discharged
receiving oral anticoagulation when the prothrom-
bin time-international normalized ratio was thera-
peutic. The dose of warfarin was regulated on an
outpatient basis to maintain an international nor-
malized ratio of 2.0 to 3.0 by a dedicated anticoag-
ulation clinic. Before discharge, clinical improve-
ment was assessed by means of an interview and
physical examination and characterized as minimal,
moderate, or severe. Patients were instructed to
engage in the normal activities of daily living, but to
avoid strenuous or repetitive exercises involving the
ipsilateral arm.
All patients were observed in our vascular clinic.
At each clinic visit, an assessment was made as to the
patient’s level of activity and disability, if any. A
color-flow venous duplex scanning study was per-
formed at each clinic visit to determine the status of
the deep venous and collateral circulation. The
patients were maintained on warfarin and were reex-
amined as outpatients after 1 month. They were
interviewed about any symptoms at rest and with
exercise and examined for swelling and the presence
of dilated superficial veins in the arm and shoulder
areas. When the patient was asymptomatic with min-
imal physical findings, the patient was maintained on
warfarin for 2 more months. At the end of this time,
the anticoagulation was discontinued, and the
patients were allowed to resume all their normal
activities, including vigorous athletic activities.
These patients were observed as outpatients toward
the end of their warfarin course, then at 6 months,
and yearly thereafter. Follow-up for the patients who
did not undergo surgery ranged from 5 to 40
months and averaged 25.8 months (Table II).
For failures of nonoperative therapy, the patient
was advised to undergo surgical decompression of
the thoracic outlet and venolysis. Specific indications
for surgery were first and most important, the per-
sistence or recurrence of symptoms of venous hyper-
tension; second, positional occlusion of venous col-
laterals with concomitant axillary-subclavian vein
thrombosis on repeat venography; and third, other
evidence of failure of anticoagulation, such as
thrombus extension or pulmonary embolus.
Our surgical approach involved a single supra-
clavicular incision. The anterior scalene muscle was
exposed in the usual manner, and the phrenic nerve
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Table I. Summary of results
Surgical Nonsurgical
Total 13 9
Sex (male/female) 7/6 6/3
Side (right/left) 9/4 6/3
Lytic therapy 11 (85%) 7 (78%)
Angioplasty 8 of 11 4 of 7
Postlysis result (complete/partial) 4/7 4/3
Symptoms at last follow-up 10 minimal/3 moderate* 9 minimal†
ASCV patency by means of duplex at last follow-up 13 (100%) 9 (100%)
*Includes one patient whose symptoms improved from a preoperative severe level to postoperative moderate level. The other two
patients’ symptoms did not significantly improve postoperatively, compared with preoperative levels.
†Includes one patient who had persistent moderate symptoms despite lack of objective findings but who, at last follow-up, at 18 months
from the initial event, had significant improvement.
ASCV, Axillary-subclavian vein.
was always identified and carefully isolated. The
anterior scalene muscle was exposed from the supe-
rior extent of our incision to its costal insertion. This
entire section of the muscle was excised, as opposed
to undergoing a simple division, to prevent a rein-
sertion through scarring. The subclavian artery and
the brachial plexus were mobilized, and the middle
scalene muscle was divided at its insertion into the
first rib and resected back to the level of the long
thoracic nerve. The first rib was skeletonized from
the surrounding structures, especially medially, deep
to the subclavian vein, and resected. Any protruding
bony spurs were resected, and all fibrous bands
impinging on the subclavian vein were divided. Care
was taken not to divide any major collateral veins
during the dissection. Finally, a complete, circumfer-
ential subclavian venolysis was performed. The sub-
clavian vein was dissected free from all soft tissues
from the lateral border of the clavicle to the subcla-
vian-jugular confluence. No attempt was made to
perform any venous reconstruction. After surgery,
the patient underwent anticoagulation for at least 1
month. When the patient had persistent symptoms,
a second venogram was performed. Balloon angio-
plasty without a stent placement was reserved for
any hemodynamically significant residual stenoses
after surgical decompression (Fig 2).7,8
Patients who underwent thoracic outlet decom-
pression were observed after 1 month and then
every 6 months. The follow-up period for these
patients ranged from 11 to 36 months and averaged
22.3 months. As with the conservatively treated
patients, an assessment was made about the patient’s
level of activity and any disability. Color-flow venous
studies were performed at each clinic visit.
RESULTS
Between June 1996 and June 1999, 22 patients
with primary axillary-subclavian vein thrombosis
were examined and treated at our hospital. The
mean age of the patients was 28.8 years (range, 18-
47 years). There were 13 male and nine female
patients. Fifteen right extremities and seven left
extremities were involved. No instance of bilateral
involvement was encountered. In 17 of 22 patients,
a distinct antecedent history of strenuous or repeti-
tive activity could be elicited before the onset of
symptoms. Of these 17 patients, five patients were
engaged in professional or collegiate varsity-level
sports, and the remainder of the patients were
engaged in recreational or occupational activity, such
as weightlifting, swimming, carrying heavy objects,
or stocking shelves above the shoulder level.
Treatment was initiated at referral institutions in
13 patients. The average duration between the initial
diagnosis and the time of examination at our institu-
tion was less than 1 month and ranged from 1 week
to 6 months. The remaining nine patients were
either primarily seen at this institution or transferred
shortly after diagnosis from referral institutions,
before the initiation of therapy. The diagnosis in 13
of the 22 patients was initially made with a color-
flow duplex venous ultrasound scan. The use of the
color-flow duplex ultrasound was dependent on the
availability of the study at the time of presentation
and the degree of clinical suspicion of the primary
physician. Four of the 13 patients initially seen at the
referral institutions underwent systemic anticoagula-
tion with intravenous heparin and started on war-
farin, but did not undergo a diagnostic venogram at
the time of initial presentation. However, all patients
eventually underwent a satisfactory contrast
venogram before beginning a definitive treatment
plan at our institution.
Eighteen of the 22 patients underwent throm-
bolysis. Sixteen patients underwent urokinase/rt-PA
treatment alone, one patient underwent combined
mechanical (percutaneous) thrombectomy and
pharmacologic thrombolysis, and one patient under-
went mechanical thrombectomy alone. The remain-
ing four patients demonstrated a patent, recanalized
but stenotic axillary-subclavian vein and collateral-
ization that did not require thrombolysis. Of the 18
patients that underwent thrombolytic therapy, initial
complete venographic evidence of clot lysis was
achieved in eight patients, and partial (more than
50%) lysis was achieved in 10 patients. In the latter
group, the initiation of thrombolytic therapy was
delayed in three of the 10 patients between 4 and 6
weeks from the onset of symptoms; the remaining
15 patients who had thrombolytic therapy were all
treated within 2 weeks of presentation. In two of the
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Table II. Nonoperative group
Collateral
Patient Months Major obstruction
number follow-up athlete on venogram
1 40 Yes No
4 36 Yes Yes
5 34 No Yes
6 33 No No
12 26 No No
15 24 No Yes
17 19 No No
20 15 No No
22 5 No Yes
eight completely lysed cases, rethrombosis occurred,
in one patient after the discontinuation of warfarin
therapy more than 1 year after the initial event and
in one patient within 2 weeks of thrombolysis,
despite adequate oral anticoagulation. The former
patient was initially treated elsewhere and would
have been offered thoracic outlet decompression
earlier had she been treated at our institution.
Thirteen of the 22 patients had documented
occlusion or marked stenosis of the axillary-subcla-
vian venous system or regional collaterals. In the
remaining nine patients, a nonocclusive contrast-fill-
ing defect at the costoclavicular junction was demon-
strated, even with the arm at rest. In more than half
of the cases (12 of 22), balloon angioplasty of these
venographic lesions was attempted, and in one of
these cases (from a referral institution), a stent was
placed. None of the 12 angioplasties resulted in any
significant venographic improvement, and in the case
of the stent placement, a fracture of the stent at the
site of the previous stenosis was demonstrated by
means of a subsequent venogram.
All patients (except one patient who never
underwent anticoagulation because of late presenta-
tion and near resolution of her initial symptoms)
were given a trial of outpatient anticoagulation.
Those patients who were nonoperatively treated
(nine of 22) underwent anticoagulation for an aver-
age of 3.6 months (range, 2-7 months). Eight of the
nine nonoperatively treated patients had minimal
symptoms at the conclusion of their anticoagulation.
The other patient had moderate, subjective symp-
toms of early arm fatigue with exercise, despite a
widely patent axillary-subclavian vein demonstrated
by means of serial venous duplex imaging, a lack of
positional occlusion by means of venography, and a
lack of physical findings by means of gross examina-
tion. Of the 13 patients who underwent surgery, five
had minimal, six had moderate, and two had severe
symptoms. Only one patient had an adverse event
during the initial observation period after thrombol-
ysis, with an acute, symptomatic rethrombosis. He
underwent an urgent second lysis and promptly
underwent surgery during the same admission. Four
of the five patients with minimal symptoms, who
underwent surgery, were involved in competitive
sports (two in baseball, one in swimming, one in
weightlifting).The fifth patient was concerned about
a possible recurrence because of his active lifestyle,
and he elected to undergo surgery rather than an
extended period of anticoagulation. Of the five
major collegiate or professional athletes in this series,
three were treated surgically (one collegiate and two
professional baseball players), and two were success-
fully treated conservatively (one collegiate football
player and one collegiate swimmer).
Eleven of the 13 patients who underwent tho-
racic outlet decompression sustained either marked
or partial resolution of their initial symptoms at their
last follow-up examination. The remaining two
patients had moderate symptoms that were relative-
ly unchanged postoperatively. With the exception of
one patient (who is also one of the two patients
whose symptoms were unchanged), all the patients
underwent anticoagulation for less than 1 month.
Five postoperative complications occurred in five
patients. They included two cases of pneumotho-
races (one required a chest tube for 2 days), one case
of chylothorax requiring a single thoracentesis, and
two cases of asymptomatic transient phrenic nerve
palsy. The average postoperative length of stay was
2.7 days (range, 2-4 days). A summary of the results
of surgical versus nonsurgical patients is shown in
Table I.
During the follow-up period, all 13 patients
maintained patency of their axillary-subclavian veins
on duplex imaging. No patient in this series required
postoperative balloon angioplasty. Those patients
who were treated conservatively continued to do
well, without the need for further intervention.
DISCUSSION
Although the clinical significance of primary axil-
lary-subclavian vein thrombosis has been increasing-
ly recognized in the last decade, the appropriate
scope and timing of treatments have remained
intensely controversial.3 The sheer number of treat-
ment algorithms and surgical approaches to thoracic
outlet decompression point to our limited under-
standing of the pathophysiology and natural history
of this disorder. The optimal treatment will likely
involve an interdisciplinary approach, with vascular
surgery and interventional radiology.
The purpose of this study was to examine the out-
comes of patients with primary axillary-subclavian
vein thrombosis who were treated with a selective and
delayed surgical treatment of their thoracic outlet syn-
drome, according to a defined treatment algorithm
(Fig 2). This approach contrasts with some of the pre-
viously published literature, which supports the
prompt surgical decompression of all patients who
have this problem.7 We began our current protocol in
1996. Since that time, we have treated 22 patients.
Like others who have reported in this area, we found
that Paget-Schroetter syndrome is frequently a condi-
tion of young patients.9 There is no particular
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predilection in either sex, but there was a preponder-
ance of the right arm (68%) over the left-upper
extremity.2 This may simply reflect the right-handed
dominance of the general population and the obser-
vation made by others that the thrombosis often
occurs on the side of the dominant extremity.8,9 A his-
tory of antecedent strenuous or repetitive activities in
more than 75% of the patients in this study confirms
the use of the term “effort vein thrombosis.”
More than half of our patients were initially treat-
ed elsewhere and were referred to us after a variable
period. Although points of controversy remain
regarding the use of adjunctive interventions after
thrombolysis, our understanding of the syndrome
during the past decade has brought near universal
acceptance of thrombolysis and anticoagulation as
the initial form of therapy. Early confirmation of axil-
lary-subclavian vein thrombosis is essential for
increasing the success of thrombolysis. In this regard,
early color-flow venous duplex scanning can be a safe
and effective means of confirming the diagnosis so
that prompt referral for venography and catheter-
directed thrombolysis can occur. In our series, nearly
60% of patients had a rapid confirmation of the diag-
nosis with color-flow venous duplex imaging.
In this study, 82% of the patients underwent
thrombolysis. Previous investigators have noted a
decreased success of lysis with an increasing duration
of time from the apparent onset of symptoms to the
initiation of lytic therapy. These studies note that
after 2 weeks, the efficacy of catheter-directed
thrombolytic therapy significantly diminishes.10
Although this study did not specifically address the
issue of thrombus age, the overall success of the ini-
tial thrombolytic therapy in this series did not appear
to have been biased by any excessive delays in the
initiation of lytic therapy, whether the treatment was
administered at our institution or elsewhere.
Positional venography has greatly contributed to
our understanding of the complex anatomy of the
venous thoracic outlet syndrome.3,7,11 Although it
may be a sufficient enough means of demonstrating a
simple stenosis of the subclavian vein in the region of
the costoclavicular junction to recommend surgical
decompression, a more compelling argument comes
with a functional demonstration of the loss of collat-
eral flow during provocative shoulder-arm maneuvers.
Diminished venous flow was documented with such
maneuvers in more than half of our patients. Previous
treatment algorithms have included this finding alone
as an indication for surgery.7,12 We believe that
although this may serve as corroborative evidence, it
does not suffice as the sole indication for surgery. In
fact, 44% of our conservatively treated patients had an
obstruction of their collateral circulation by means of
venography but remained asymptomatic and, there-
fore, did not undergo surgery (Table II).
Post-thrombolytic balloon angioplasty of stenot-
ic lesions without surgical decompression and veno-
lysis has been largely unsuccessful and is not recom-
mended.6,13,14 The experience of this study confirms
this view. Lesions frequently seen by means of com-
pletion venography after successful thrombolysis
represent extrinsic compression from fixed, muscu-
loskeletal structures of the thoracic outlet and can-
not be corrected with adjunctive stenting. As we and
other authors have noted, the result is a fracture of
the stent.15 Most stents are not designed to with-
stand the repetitive crushing strain between two
bony structures, and currently, no stent has the radi-
al strength to maintain a distraction of an area such
as the costoclavicular space.
Nearly all the patients (21 of 22) underwent oral
anticoagulation for variable periods. Conventional
management of lower-extremity deep venous throm-
bosis involves anticoagulation for 3 to 6 months.
This practice has been, to a large part, carried over to
the initial conservative treatment of upper-extremity
venous thromboses. The trend has been, however,
toward shortening the duration of oral anticoagula-
tion in cases of primary axillary-subclavian vein
thrombosis. Some investigators have noted that this
initial period of anticoagulation places the patient at
an increased risk of rethrombosis.16 In our series, this
occurred in only one case, which was immediately
treated with a second course of thrombolysis, with-
out any long-term sequelae. Furthermore, prompt
surgery shortly after thrombolysis could decrease the
total duration of anticoagulation to as little as 1
month postoperatively. We agree that, although this
would eliminate the inconvenience of interval antico-
agulation and a second admission for heparin transi-
tion before surgery, this approach de facto commits
all patients to surgery, which, we would submit, is
not always necessary. Furthermore, surgical dissec-
tion can be more difficult with the acute inflamma-
tion surrounding a recently thrombosed vein.8,14
Close follow-up and gradual return to full physical
activity allowed a significant percentage of patients
(more than 40%) to achieve a baseline, premorbid
status without the need for surgery or prolonged
anticoagulation beyond the usual period.
In this series, nearly 60% of the patients (13 of 22)
eventually underwent surgery. More than half of these
patients (seven of 13) came to surgery before comple-
tion of their outpatient anticoagulation course. This
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demonstrates the need for close observation, including
serial color-flow venous duplex ultrasound scanning.
In most cases, there was minimal perivenous
inflammation, which facilitated a safe venolysis. As pre-
viously noted, this may be a result of allowing at least
1 month of oral anticoagulation before surgery so that
the acute thrombophlebitis has had a chance to
become quiescent. None of the patients required sur-
gical venous reconstruction or open thrombectomy.
This partially reflects our experience from a previously
published series, in which half of all direct venous
reconstructions had failed on follow-up examination.6
Furthermore, we believe that a complete decompres-
sion of the thoracic outlet and of the collateral circula-
tion is perhaps more critical than reestablishing flow in
the axillary-subclavian vein per se in preventing the
recurrent symptoms of venous obstruction.7,18
We favor the supraclavicular approach over a trans-
axillary, paraclavicular, or other combined approaches
to the thoracic outlet, because it allows two surgeons
to work together over a wider operative field and offers
a clear exposure of the three key structures that con-
tribute to the axillary-subclavian thrombosis: the first
rib, the anterior scalene muscle, and the subclavian
vein. We have not found it necessary to make any
counterincisions or secondary exposures, although, as
other authors have noted, this may be required in
some patients.11,13 Furthermore, although some
investigators have advocated a selective removal of one
or two structures on the basis of intraoperative find-
ings,13 we favor a complete resection of the first rib
and the scalene muscles. This ensures the elimination
of all possible anatomic causes of subclavian vein com-
pression during the initial operation, with minimal risk
and morbidity. If a patient were to have recurrent
symptoms, a reoperation to remove a residual struc-
ture would be much more hazardous.
In summary, we draw these conclusions based on
our experience of a selective surgical approach to the
treatment of primary axillary-subclavian thrombosis.
First, not all patients with axillary-subclavian vein
thrombosis require surgery. A period of close follow-
up while patients undergo oral anticoagulation is
warranted to select patients who will do well with
conservative treatment alone, especially given the
potentially serious neurovascular complications of
operative intervention. Second, mainly symptoms
and confirmatory positional venography should
guide surgical therapy. In those cases that do come
to surgery, a supraclavicular approach with resection
of the first rib, scalene muscles, and venolysis is safe
and effective, and adjunctive venous reconstruction
is not routinely necessary. Finally, although there
may be a role for postoperative endovascular therapy
in a very small subset of patient with refractory
symptoms, there is currently no role for preoperative
endovascular treatment beyond thrombolysis.
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Dr Eric S. Weinstein (Englewood, Colo). I would like
to congratulate Dr Lee for an excellent presentation of this
interesting paper and thank the authors for providing me
with a copy of the manuscript in a timely fashion to review
prior to the meeting.
A selective approach to surgical therapy in cases of neu-
rogenic thoracic outlet syndrome has been shown to
improve overall outcome for patients with this condition.
According to these authors, the same may be true for
patients with venous thoracic outlet compression syn-
dromes. Based upon their preliminary studies, the Stanford
group’s treatment algorithm for patients with effort throm-
bosis was prospectively evaluated to examine the outcomes
of patients treated with or without surgery following initial
thrombolytic therapy and a short period of outpatient anti-
coagulation and observation. Their conclusion that “not all
patients with primary axillary-subclavian vein thrombosis
requires surgical intervention” is provocative.
I have several comments and questions for the
authors. The first relates to the inclusion criteria for
patients in this review. The purpose of the study, as stated
in the manuscript, was to evaluate both operative and non-
operative management following thrombolytic therapy
and develop selection criteria for surgery for patients with
this syndrome. However four out of 22 patients presented
with recanalized axillo-subclavian veins and thus did not
undergo lytic therapy. In my opinion these patients may
have already self-selected the appropriate treatment and
cannot truly be considered to be in the acute phase of
their illness. In addition their surgical therapy may be dif-
ferent from those presenting acutely (ie, jugular vein turn-
down vs rib resection). They therefore warrant a separate
consideration. Why did the authors feel it appropriate to
include these patients among the 18 who presented with
acute thrombosis requiring intraclot lysis?
My second question addresses the activity level of the
nonoperatively managed group. For all patients in the
series, the initial 4 weeks of anticoagulation is accompa-
nied by a gradual return to nonstrenuous activity. Patients
who where asymptomatic or only mildly impaired were
managed with an additional 2 months of anticoagulation.
Did these patients return to their previous activity levels
that precipitated the thrombosis or did they require per-
manent modification of their activities to remain asympto-
matic? It has been our experience that many of our
patients who were either professional or amateur athletes
or whose occupation required repetitive arm activity above
their shoulders were adamant in their desires to return to
their previous activity level and were able to do so follow-
ing surgical treatment.
My third question has to do with those patients in
your series with incomplete clot lysis and/or residual sub-
clavian vein stenosis of more than 50% following urokinase
treatment. I wholeheartedly agree with the authors that
balloon angioplasty has no role in the treatment of this
disease prior to rib resection. We have seen several cases of
acute thrombosis secondary to an ill-conceived angioplas-
ty in this setting. However, I am also concerned about
treating a > 90% residual vein stenosis with anticoagula-
tion alone. In such situations we have kept these patients
on a heparin drip and operated the next day performing
first-rib resection, venolysis, and, in selected cases, venous
reconstruction, with excellent results. My question for the
authors is in cases where there is a critical (> 80%) residual
stenosis following lysis, do you still advocate conversion to
outpatient anticoagulation or do you recommend early
surgical intervention in the severely symptomatic patient?
Although the author saw only one case of early rethrom-
bosis, how many of their patients had > 80% residual vein
stenosis following lysis?
Finally, my last comments and questions focus on the
surgical approach. We feel that the supraclavicular
approach is the procedure of choice for those patients with
neurogenic TOS; however it has some significant limita-
tions in cases of venous thrombosis.
First, the supraclavicular incision places the major col-
laterals from the subclavian to the jugular vein at risk.
These can be more easily avoided with a transaxillary or
infraclavicular approach. Second, in our experience, the
structures that produce the venous constriction (namely
the hypertrophied subclavius muscle and more important
the costoclavicular ligament) are more easily and com-
pletely accessed via these alternative approaches in order
to perform a complete venolysis. In addition, we have
found it often necessary to remove the very proximal rib
and cartilage to the sternochondral junction in order to
completely free up the proximal vein and prevent recur-
rent symptoms. In our experience, this cannot be safely
reached via the supraclavicular incision alone. In Denver,
our approach has been to perform transaxillary first-rib
resection for cases in which there is minimal or no fixed
stenosis of the subclavian vein following lysis. An infra-
clavicular approach is utilized when we feel that there is a
possibility that a venous reconstruction may be necessary.
We are presently compiling our data on approximately two
dozen patients treated in this manner in which it was nec-
essary to perform endovenectomy and vein patch angio-
plasty in six patients with a markedly stenotic subclavian
vein following lysis and rib resection. The authors in this
series had no patients who required venous reconstruction
and advocated possible delayed angioplasty for residual
thrombosis following rib resection secondary to a relative-
ly high rate of rethrombosis following venous reconstruc-
tion in their previous experience. We have not seen this in
our recent series, and I wonder if this may have been a
result of residual ligament or rib remnant secondary to
their operative approach.
Although we are less enamored with the results of bal-
loon angioplasty in these cases, I would stress the word
delayed in the authors’ recommendations for treatment of
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residual vein stenosis. The Albany group has recommend-
ed immediate angioplasty following rib resection. We have
seen one case of a ruptured subclavian vein and nearly
exsanguinating hemorrhage when this was performed and
do not share their enthusiasm for early treatment.
Again, I would like to congratulate the authors on an
excellent presentation and thank the society for the oppor-
tunity to discuss this fine paper.
Dr W. Anthony Lee. Thank you, Dr Weinstein. I
would like to first say that we recognize the limitations of
our study with its relatively small numbers and short fol-
low-up. To that end we would welcome an opportunity to
present a follow-up report in the future to the society
regarding these patients and additional patients that will
be accrued. 
Dr Weinstein first asked about our inclusion criteria,
more specifically regarding our inclusion of the four patients
who presented from outside institutions without undergo-
ing a venogram and thrombolysis. It is true that they do
represent a subset of patients who presented in a different
manner compared with the 18 other patients. However, we
felt their primary pathophysiology and pathology did fall
under the label of primary axillary subclavian vein throm-
bosis and that they were appropriate to be included.
In addition, the lack of an acute thrombosis at the
time of their presentation at our institution on a venogram
precluded them from undergoing thrombolysis.
In regard to your second question concerning gradual
increase of patient activity and how these patients were
advised, our recommendation was to gradually increase
their activity and not to engage in strenuous or repetitive
activity immediately. How exactly they interpreted that
advice I cannot specifically comment.
In regard to the small subset of young individuals who
were either very physically active or involved in profes-
sional or collegiate level varsity sports, in many ways they
had the most to lose and in some ways the most to gain
from a successful outcome, whether it be conservative or
surgical management.
In these patients, despite still being on the team, either
from their coaches or fear of incurring additional injury,
they have voluntarily reduced the intensity of their activi-
ties compared with their premorbid levels.
Regarding cases of incomplete lysis, we agree that
there is no role for preoperative balloon angioplasty of
these lesions. I cannot tell you exactly how many of these
patients out of the 10 that achieved only partial lysis fell
into the category of 80% to 90%. Whether these people
should also be considered for conservative treatment, yes,
I believe we should.
I think what we are starting to appreciate from this
series and treating these people over time is that, in fact,
the venous collaterals may be more physiologically impor-
tant than the named subclavian or axillary vein itself and
that even with visualization of 80% to 90% or near occlu-
sive stenosis, these people should be given a chance to
declare themselves.
Lastly, in terms of technical aspects of the operation,
indeed much has been written about various approaches,
namely, transaxillary and also the so-called paraclavicular
approaches where combined supraclavicular and infraclav-
icular approaches are used. We can imagine where there
may be circumstances where other surgical approaches
may seem more appropriate.
However, I believe that most of these arguments have
to do with local expertise, and in our hands the supraclav-
icular approach has afforded us extremely good visualiza-
tion and an opportunity for two surgeons to work togeth-
er with a clear view of the field. We have been able to reach
the most medial aspects of the first rib and subclavian vein
without much difficulty.
Dr Robert Rutherford (Denver, Colo). One cannot
really argue with your title that says not all patients require
operation. Certainly those with a normal venogram after
lysis and a negative positional venogram one would cer-
tainly observe. On the other hand, I am not sure I can
agree that if you get away without surgery in nine out of
22 that you can claim after a short follow-up, they did not
require surgery. 
What I understood from your presentation was that,
after about a month on anticoagulants, these patients, as
you say, “declare themselves,” and that you made your
selection mainly on the basis of symptoms, that is, the
patients’ symptoms with return to activity.
On the other hand, five of the nine patients you oper-
ated on had minimal symptoms but were athletes. So there
is more to your selection process.
So I would like to know a little more about your selec-
tion process. I think it is possible to select patients you do
not operate on, but were you not influenced at all by other
considerations, particularly the venographic findings; by
the residual intrinsic lesions; or by extrinsic compression
on positional venography? Was the decision really entirely
made on the basis of symptoms?
Dr Lee. Thank you for your questions. I would like to
respond to that by saying that indeed our primary indica-
tion is the presence of symptoms. We have found that in a
majority of these individuals with hyperabduction and
external rotation you can obtain some level of venous
occlusion or obstruction. However, on top of that, we
have added an additional condition that not only should
they occlude the main named vessels, but also the collat-
erals as demonstrated in one of our slides.
I think the real answer behind this controversy
remains what is the true pathophysiology behind primary
axillary subclavian thrombosis? Review of the literature
seems to show conflicting understanding of the problem.
I think the future may bear out that the presence of col-
laterals may be more important than initially suspected.
In regard to your point about our surgical therapy for
five of those patients who had preoperatively minimal
symptoms, these involved primarily athletes and those who
were very physically active. They had minimal symptoms
insofar as being able to participate in many of their nonath-
letic activities. However, they expressed strong concern
about possible recurrence. They also showed some aversion
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to the prospect of any increased duration of anticoagula-
tion that was other than absolutely necessary. Given the
prospect of a shorter period of anticoagulation, even at the
risk of surgery, they wished to undergo surgery.
Dr Julie A. Freischlag (Los Angeles, Calif). I rise to sort
of tell you we do it different. It has taken three of us to take
over Dr Machleder’s incredible practice at UCLA, and we
do see a lot of effort thrombosis. I have been quite frustrat-
ed that the majority are treated initially somewhere else, and
in your series see that you are seeing the same thing: that
60% to 70% of these patients we see after someone has tried
to lyse and balloon them. It is usually 4 to 6 weeks later.
I like operating on this group of patients because they
get better, and I think that is the difference I like about
the effort thrombosis patients. Unlike neurogenic
patients, that even if you select them carefully, there is
always a ringer that you did not make better or that is
going to call you and be in your office frequently.
The effort thrombosis patients tend to be very active
individuals who want to go have a life, and therefore, they
go do that. And, therefore, I rise to say that I love operat-
ing on these patients, and there are very few of them I
would elect not to operate on.
I find that they tend to be gladiators. They are very
active. They are weight lifters. They are surfers. Actually, I
have two surfers wearing their ribs around their neck now
in San Luis Obispo. I think they are a group of patients
that actually would do well perhaps without surgery
because they are going to go ahead anyway, but I think
you can make them better.
My frustration with them coming late is that we do see
patients with an occluded vein when they come that you
think you could have treated. My one question to you is
what do you do with someone who is occluded and has
only collaterals?
I do agree with you the collaterals are important, and
I have operated on a handful of patients who have prima-
ry thrombosis of the vein and only patent collaterals. We
resect the rib, and we are unable to open up the main vein,
but they are better, and I think you can make a difference. 
We have gotten more aggressive in doing this faster.
Dr Machleder initially wrote about waiting 3 months. We
have gone to 1 month, and Dr Gelabert is actually doing
similar to what Dr Weinstein mentioned. Some patients, if
we do get to see them first, and we do lyse open their vein
and will resect the rib during the same hospitalization.
However, I have had one patient develop hemorrhage
following a vein angioplasty in hospital 2 days following
the rib resection. The bleeding was from the bed of the
rib, and this patient required a thoracotomy with a hemo-
thorax. Therefore, I think I too would delay the angio-
plasty a couple weeks later after the rib resection.
I enjoyed your comments. We still do this procedure
transaxillary. Certainly across the nation there are good results
with both types of surgical approaches with this disease.
Dr Lee. Dr Freischlag, thank you very much for your
comments. I believe that some thromboses are silent.
However, if we do encounter a patient who does come
back with a recurrent thrombosis after what we felt was a
period of adequate anticoagulation, those patients would
be restudied, they would be reimaged, and relysis would be
attempted, and given this recurrent episode, they would be
strongly considered and recommended for surgical therapy.
Dr Cornelius Olcott IV. Well, I told Anthony this was
going to raise some shackles in this organization, and I feel
I am kind of compelled to get him off the hook a little bit.
The surgeons that have discussed this paper are all
excellent surgeons. However, I am sure they have seen
patients that have been operated on and have had bad
results because of brachial plexopathies, subclavian artery
injuries, and persistent lymphatic leaks, etc.
Because of some of the bad results that we have seen,
thankfully not in our institution, we have pursued this
conservative approach, operating on only those patients
with persistent symptoms of venous hypertension.
We are not trying to tell you on the basis of relatively
short follow-up that this is the ultimate answer, but I
believe we can say on the basis of this study that a conser-
vative approach should be considered. There is little
downside, and some patients are spared surgical 
intervention.
Also, a little delay we believe helps because the subcla-
vian vein is not as inflamed, thus making the surgery tech-
nically easier. Thank you.
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